Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients

Table 2

Comparison of treatments during hospitalization between MACE and nonMACE groups.

	MACE	NonMACE	value
receptor antagonist	10 (45.5%)	83 (67.5%)	0.047
ACEI/ARB	7 (31.8%)	65 (52.8%)	0.069
Diuretics	18 (81.8%)	89 (72.4%)	0.353